Guideline | Country (region) | Year | Country income classification* | Target populations | Overall quality score |
China (MoH)54 | China | 2003 | UMC | A | 1 |
Dermatology Advisor47 | Global | 2017 | – | C, P, A, O, H | 1 |
DermNet48 | Global | 2014 | – | C, A | 2 |
ECDC56 | Europe | 2019 | – | A | 1 |
eMedicine49 | Global | 2020 | – | A | 1 |
Ireland HPSC53 | Ireland | 2021 | HIC | A | 1 |
Medscape51 | Global | 2019 | – | A | 2 |
NCDC44 | Nigeria | 2019 | LMIC | C, A, H | 3 |
PHE/UKHSA52 | England | 2019 | HIC | A | 1 |
Singapore FETP46 | Singapore | 2020 | HIC | A | 3 |
Taiwan CDC45 | Taiwan | 2009 | UMC | C, P, A, H | 1 |
UpToDate50 | Global | 2021 | – | C, P, A | 6 |
US CDC55 | USA | 2018 | HIC | A | 2 |
WHO18 | Global | 2019 | – | A | 1 |
*World bank country income classification 57
A, adults; C, children; CDC, Centers for Disease Control; ECDC, European Centres for Disease Control and Prevention; FETP, Singapore Field Epidemiology Training Programme; H, people living with HIV/immunosuppression; HIC, high-income country; HPSC, Health Protection Surveillance Centre; LMIC, lower-middle-income country; MoH, Ministry of Health; NCDC, Nigeria Centre for Disease Control; O, older adults; P, pregnant women; PHE, Public Health England; UKHSA, UK Health Security Agency; UMC, upper-middle-income country.